(A) Representative images of medial prefrontal cortex vasculature staining for PECAM1. (B) Quantification of PECAM1 area in medial prefrontal cortex layer II/III: Grouped 2.468% ± 0.3156 n = 6 mice, Isolated 2.086 ± 0.13 n = 6 mice (mean ± standard error). Mann-Whitney test. (C) Quantification of number of Pecam1 mRNA expressing cells per field of view. Grouped 9 ± 0.5888 n = 4 mice, Isolated 8.44 ± 1.162 n = 4 mice (mean ± standard error). Mann-Whitney test. (D) Quantification of the number of Pecam1 mRNA molecules. Grouped 13.47 ± 6.204 n = 77 cells from four mice, Isolated 10.89 ± 5.02 n = 92 cells from five mice (mean ± standard deviation). Mann-Whitney test, p=0.002. (E) Quantification of the number of Pecam1 mRNA molecules per mouse. Grouped 13.53 ± 1.305 n = 4 mice, Isolated 10.48 ± 1.018 n = 5 mice (mean ± standard error). Mann-Whitney test. (F) Quantification of the number of Edn1 mRNA molecules in Pecam1 positive endothelial cells. Grouped 12.08 ± 9.759 n = 77 cells from four mice, Isolated 4.837 ± 4.406 n = 92 from five mice (mean ± standard deviation). Mann-Whitney test, p<0.0001. (G) Quantification of the number of Edn3 expressing Pecam1 positive endothelial cells. Grouped 0.5463 ± 0.01586 n = 5 mice, Isolated 0.3674 ± 0.02163 n = 5 mice (mean ± standard error). Mann-Whitney test, p=0.0079.